Pubblicazioni

How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)

2020 - CANCER MEDICINE

Breccia, Massimo; Olimpieri, PIER PAOLO; Olimpieri, Odoardo; Pane, Fabrizio; Iurlo, Alessandra; Foggi, Paolo; Cirilli, Alessia; Colatrella, Antonietta; Cuomo, Marcello; Gozzo, Lucia; Summa, Valentina; Corradini, Paolo; Russo, Pierluigi; Monitoring Registries Group, AifaâS